Hirsutism: from Brazil to a place near you

Bibliography

• Wheeland RG. Simulated consumer use of a battery-powered, hand-held, portable diode laser (810 nm) for hair removal: a safety, efficacy and ease-of-use study. Lasers Surg Med 2007;39:476-93
   PubMedGoogle Scholar
• Alster TS, Tanzi EL. Effect of a novel low-energy pulsed-light device for home-use hair removal. Dermatol Surg 2009;35:483-9
   PubMedGoogle Scholar
• Randall V. Androgens the main regulator of human hair growth. In: Camacho FM, Randall VA, Price VH, editors, Hair and its disorders biology, pathology and management. London: Martin Dunitz Ltd; 2000
   Google Scholar
• Martin KA, Chang RJ, Ehrmann DA, Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:1105-20
   PubMed Web of Science ®Google Scholar
• Van Scott EJ, Ekel TM. Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol 1958;31:281-7
   PubMedGoogle Scholar
• Elliott K, Stephenson TJ, Messenger AG. Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol 1999;113:873-7
   PubMed Web of Science ®Google Scholar
• Yoo HG, Won CH, Lee SR, Expression of androgen and estrogen receptors in human scalp mesenchymal cells in vitro. Arch Dermatol Res 2007;298:505-9
   PubMedGoogle Scholar
• Randall VA, Hibberts NA, Thornton MJ, The hair follicle: a paradoxical androgen target organ. Horm Res 2000;54:243-50
   PubMedGoogle Scholar
• Zouboulis CC, Chen WC, Thornton MJ, Sexual hormones in human skin. Horm Metab Res 2007;39:85-95
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-88
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7
   PubMed Web of Science ®Google Scholar
• Ehrmann DA. Hirsutism and virilization. In: Anthony S, Fauci EB, Dennis L, , editors, Harrison's Online: McGraw-Hill's AccessMedicine; 2008
   Google Scholar
• Ito M, Kizawa K, Hamada K, Cotsarelis G. Hair follicle stem cells in the lower bulge form the secondary germ, a biochemically distinct but functionally equivalent progenitor cell population, at the termination of catagen. Differentiation 2004;72:548-57
   PubMed Web of Science ®Google Scholar
• Wagner RF Jr. Medical and technical issues in office electrolysis and thermolysis. J Dermatol Surg Oncol 1993;19:575-7
   PubMedGoogle Scholar
• Olsen EA. Methods of hair removal. J Am Acad Dermatol 1999;40:143-55; quiz 156-147
   PubMed Web of Science ®Google Scholar
• Haedersdal M, Wulf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006;20:9-20
   PubMed Web of Science ®Google Scholar
• Wolf JE Jr, Shander D, Huber F, Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 2007;46:94-8
   PubMed Web of Science ®Google Scholar
• Hoffmann R. A 4-month, open-label study evaluating the efficacy of eflornithine 11.5% cream in the treatment of unwanted facial hair in women using TrichoScan. Eur J Dermatol 2008;18:65-70
   PubMed Web of Science ®Google Scholar
• Smith SR, Piacquadio DJ, Beger B, Littler C. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg 2006;32:1237-43
   PubMed Web of Science ®Google Scholar
• Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007;57:54-9
   PubMed Web of Science ®Google Scholar
• Spironolactone. MIMS Online. MIMS Australia & UBM Medica. St Leonards, NSW; 2008
   Google Scholar
• Brown J, Farquhar C, Lee O, Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2009;CD000194
   Google Scholar
• Lobo R A, Shoupe D, Serafini P, The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril 1985;43:200-5
   PubMedGoogle Scholar
• Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev 2003;CD001125
   Google Scholar
• Lakryc EM, Motta EL, Soares JM Jr, The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Gynecol Endocrinol 2003;17:57-63
   PubMed Web of Science ®Google Scholar
• Moghetti P, Tosi F, Tosti A, Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2000;85:89-94
   PubMed Web of Science ®Google Scholar
• Beigi A, Sobhi A, Zarrinkoub F. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Int J Gynaecol Obstet 2004;87:29-33
   PubMed Web of Science ®Google Scholar
• Lumachi F, Rondinone R. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism. Fertil Steril 2003;79:942-6
   PubMed Web of Science ®Google Scholar
• Muderris II, Bayram F, Guven M. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 2000;73:984-7
   PubMed Web of Science ®Google Scholar
• Falsetti L, Gambera A. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism. Fertil Steril 1999;72:41-6
   PubMed Web of Science ®Google Scholar
• Bayram F, Muderris, II, Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism. Eur J Endocrinol 2002;147:467-71
   PubMed Web of Science ®Google Scholar
• Tartagni M, Schonauer M M, Cicinelli E, Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women. Fertil Steril 2004;82:752-5
   PubMed Web of Science ®Google Scholar
• Swiglo BA, Cosma M, Flynn DN, Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008;93:1153-60
   PubMed Web of Science ®Google Scholar
• Sahin Y, Dilber S, Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2001;75:496-500
   PubMed Web of Science ®Google Scholar
• Gokmen O, Senoz S, Gulekli B, Isik A Z. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome. Gynecol Endocrinol 1996;10:249-55
   PubMed Web of Science ®Google Scholar
• Tartagni M, Schonauer LM, De Salvia MA, Comparison of diane 35 and diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2000;73:718-23
   PubMed Web of Science ®Google Scholar
• Cosma M, Swiglo BA, Flynn DN, Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008;93:1135-42
   PubMed Web of Science ®Google Scholar
• Metformin. MIMS Online. MIMS Australia & UBM Medica. St Leonards, NSW; 2008
   Google Scholar
• TriaBeauty I. TriaBeauty. Laser hair removal at home. At last. In, 2009
   Google Scholar
• Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf) 2008;68:800-5
   PubMed Web of Science ®Google Scholar